07/25/2017 13:49:21
Lori Dajose
Genetically engineered viruses help the immune system target specific pathogens in unexpected ways.
07/15/2016 09:40:40
Whitney Clavin
Scientists are learning how cells make the decision to become T cells.
09/11/2015 08:58:01
Jessica Stoller-Conrad
Broadly neutralizing antibodies (bNAbs) are thought to be the future for treating and preventing HIV infections. A bNAb recently characterized by Caltech researchers can neutralize HIV in different states—increasing the antibody's promise as a therapeutic.
03/27/2015 08:49:26
Douglas Smith
Finding an anti-AIDS vaccine remains an elusive goal—partly because the HIV virus quickly mutates to evade the vaccine's antibodies. In a Watson Lecture on April 1, Caltech's Pamela J. Bjorkman will describe ways to neutralize that mutational advantage.
01/29/2015 09:23:04
Kimm Fesenmaier
Caltech researchers have developed antibody-based molecules that are hundreds of times better than our natural defenses at binding to and neutralizing the HIV virus.
09/18/2014 09:24:46
Kimm Fesenmaier
Researchers around the country are adopting a technique developed in the Caltech lab of Nobel Laureate David Baltimore to try to guard against infection. The method, called VIP, was originally designed to trigger an immune response to HIV.
02/09/2014 10:05:05
Kimm Fesenmaier
"The method that we developed has now been validated in the most natural possible setting in a mouse," says David Baltimore, president emeritus and the Robert Andrews Millikan Professor of Biology at Caltech.
01/30/2014 14:02:45
Katie Neith
Researchers at Caltech are the first to have utilized high-resolution electron microscopy to look at HIV infection within the actual tissue of an infected organism, providing perhaps the most detailed characterization yet of HIV infection in the gut.
11/15/2013 11:02:14
Caltech researchers have demonstrated a method for using a lab-on-a-chip device and a cell phone to determine a concentration of molecules, such as HIV RNA molecules, in a sample.
10/08/2012 16:28:37
Katie Neith
Years spent studying HIV in the lab were beginning to make Pamela Bjorkman feel disconnected from the possible impact of her work. So this summer she visited India, spending time with HIV-positive women and others who are at risk.
Subscribe to Caltech News tagged with "HIV"